Skip to reading

Take a closer look at NAD+

NAD+ itself, ingredients that help make it, and injections are different things—here’s how to tell them apart.

Three offset household shelves with separate unlabelled jars of grains in soft afternoon light

01 / The molecule

The molecule your cells use

A plain glass jar of barley on a pale wooden pantry shelf
A name is a starting point. The contents tell you more.

NAD+ helps cells use energy and supports processes such as DNA repair. Its full name is nicotinamide adenine dinucleotide. You’ll usually see it called a coenzyme, which means a helper for enzymes, the proteins that make reactions happen. The cell biology explains the interest.

But having a useful job inside a cell doesn’t tell us what taking extra will do. That’s a separate question, and it needs a study of the actual ingredient and route. The name alone can’t answer it.

02 / Oral precursors

Ingredients that help make NAD+

Separate unlabelled jars of rice and rolled oats on a household shelf
NR and NMN have their own names for a reason.

Nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) are precursors: ingredients the body uses to make NAD+. They aren’t other spellings of NAD+. An oral NR study is a study of NR, even if the headline talks about NAD+.

In one trial, oral NR raised NAD+ in whole blood. That’s a real result. Whether people became healthier is another question. And a milligram number only helps once you know which ingredient was given and how.

03 / Injectable preparations

An injection adds questions

Two pantry shelves with a jar of lentils and open space between ordinary kitchen contents
Same shelf, different contents. Keep the names separate.

An IV infusion puts a preparation into a vein. It tells you how something gets into the body, not what benefit to expect. A small NAD+ infusion study measured changes in blood and urine. It didn’t show heart protection.

Compounded medicines are prepared rather than supplied as an approved finished drug. They are not FDA-approved. Who made the preparation, what’s in it and what checks were done all deserve attention.

Shared question / 1

What actually changed?

Heart and metabolic claims can sound like one big story. The studies below are three different stories: rats given NAD+, women taking NMN, and men in an infusion pilot. Keeping those details visible makes the findings much easier to judge.

There’s no need to dismiss an early result. Just keep the result with the people or animals, ingredient and route that produced it. That’s where its meaning lives.

The molecule / Animal work

Less heart damage in rats

In a rat heart injury experiment, intravenous NAD+ reduced the area of damaged heart muscle. That explains some of the interest in heart health. It doesn’t show that an infusion prevents heart attacks in people.

Oral precursors / Human trial

A change in muscle response

In prediabetic, postmenopausal women taking oral NMN, muscle became more responsive to insulin. Body composition and a longer-term blood-sugar marker didn’t change. This was a specific metabolic finding, rather than proof of heart protection.

Injectable preparations / Human pilot

Blood and urine measurements

The human infusion pilot followed NAD+ and related substances in blood and urine. Those measurements help explain what happens during an infusion. They don’t, by themselves, show that someone’s health improved.

Shared question / 2

What’s known about the preparation?

For a compounded medicine, the ingredient is only part of the picture. FDA warns that compounding errors can cause contamination or incorrect strength. A prescription doesn’t remove those risks.

Short studies also leave questions about longer use. Before treating a familiar name as reassurance, ask what supports the benefit and what’s known about safety. Our questions page helps untangle those two conversations.